Skip to main content
Home
Drug Metabolic Roadmap (2024 update)
★
Drug Metabolic Roadmap
★
Drug Metabolite
★
Metabolic Reaction
DME Interactome
Microbiome-DME Interaction
Host Protein-DME Interaction
Xenobiotics-DME Interaction
Download
Help
Drug Information
Drug General Information
Drug ID
D05WQN
Former ID
DNC011204
Drug Name
N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide
Drug Type
Small molecular drug
Indication
Discovery agent
Investigative
[
531067
]
Formula
C16H20N2O
Canonical SMILES
CC1=CC2=C(N1)C=CC(=C2)NC(=O)C3CCCCC3
InChI
1S/C16H20N2O/c1-11-9-13-10-14(7-8-15(13)17-11)18-16(19)12-5-3-2-4-6-12/h7-10,12,17H,2-6H2,1H3,(H,18,19)
InChIKey
VFQGCSZINPSFBG-UHFFFAOYSA-N
PubChem Compound ID
46400456
Target and Pathway
Target(s)
Amine oxidase [flavin-containing] A
Target Info
Inhibitor
[
531067
]
Amine oxidase [flavin-containing] B
Target Info
Inhibitor
[
531067
]
BioCyc Pathway
Superpathway of tryptophan utilization
Dopamine degradation
Putrescine degradation III
Noradrenaline and adrenaline degradation
Serotonin degradation
Superpathway of melatonin degradation
Melatonin degradation IIPWY66-401:Superpathway of tryptophan utilization
Tryptophan degradation via tryptamine
KEGG Pathway
Glycine, serine and threonine metabolism
Arginine and proline metabolism
Histidine metabolism
Tyrosine metabolism
Phenylalanine metabolism
Tryptophan metabolism
Drug metabolism - cytochrome P450
Metabolic pathways
Serotonergic synapse
Dopaminergic synapse
Cocaine addiction
Amphetamine addiction
Alcoholismhsa00260:Glycine, serine and threonine metabolism
Alcoholism
NetPath Pathway
IL4 Signaling Pathway
PANTHER Pathway
Adrenaline and noradrenaline biosynthesis
5-Hydroxytryptamine degredation
Dopamine receptor mediated signaling pathwayP00001:Adrenaline and noradrenaline biosynthesis
Dopamine receptor mediated signaling pathway
Pathway Interaction Database
Alpha-synuclein signaling
PathWhiz Pathway
Histidine Metabolism
Tyrosine Metabolism
Glycine and Serine Metabolism
Reactome
Norepinephrine Neurotransmitter Release Cycle
WikiPathways
SIDS Susceptibility Pathways
Biogenic Amine Synthesis
Oxidative Stress
Dopamine metabolism
Phase 1 - Functionalization of compounds
Neurotransmitter Release Cycle
Neurotransmitter Clearance In The Synaptic Cleft
Serotonin Transporter ActivityWP465:Tryptophan metabolism
References
Ref 531067
Eur J Med Chem. 2010 Oct;45(10):4458-66. Epub 2010 Jul 31.Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Ref 531067
Eur J Med Chem. 2010 Oct;45(10):4458-66. Epub 2010 Jul 31.Inhibition of monoamine oxidase by indole and benzofuran derivatives.
If you find any error in data or bug in web service, please kindly report it to
Dr. Yin
and
Dr. Li
.